Cancer control funding in Nigeria: A case for universal health coverage.

Cancer control funding Health financing Nigeria cancer control Nigeria cancer policy Universal health coverage for cancer

Journal

Journal of cancer policy
ISSN: 2213-5383
Titre abrégé: J Cancer Policy
Pays: England
ID NLM: 101639933

Informations de publication

Date de publication:
06 2022
Historique:
received: 19 01 2022
revised: 02 04 2022
accepted: 27 04 2022
pubmed: 18 5 2022
medline: 7 6 2022
entrez: 17 5 2022
Statut: ppublish

Résumé

Nigeria's health spending per capita remains relatively low, with an out-of-pocket expenditure on health estimated at three-quarters of the nation's health expenditure in 2018. A large percentage of the population cannot afford-and have limited access to-cancer treatment services. Our study was aimed at analyzing all cancer funding-related policies from 2010 to 2020. We used qualitative methods to contextualize the challenges of funding cancer control, and recommend steps in policy implementation needed to achieve universal health coverage (UHC) for cancer care in Nigeria. We found that cancer control is grossly underfunded, with a glaring lack of political will identified by most participants as the root cause of underfunding. Recommendations by the participants included mandatory enrollment in health insurance schemes, encouraging public-private partnerships and advocacy for increased taxation to democratize access to treatment. Additionally, channeling a portion of tax revenues from tobacco sales to cancer will reduce catastrophic health spending and move Nigeria closer toward achieving UHC for cancer.

Identifiants

pubmed: 35580822
pii: S2213-5383(22)00014-5
doi: 10.1016/j.jcpo.2022.100335
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100335

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Kingsley Ndoh (K)

University of Washington Department of Global Health, Seattle, WA, USA. Electronic address: kndoh@uw.edu.

Aliko Ahmed (A)

Chatham House Center for Universal Health, London, United Kingdom; Public Health England, London, United Kingdom.

Robert Yates (R)

Chatham House Center for Universal Health, London, United Kingdom.

Isaac Adewole (I)

College of Medicine, University of Ibadan, Nigeria.

Zainab Bagudu-Shinkafi (Z)

Medicaid Cancer Foundation, Abuja, Nigeria.

Folakemi Odedina (F)

Mayo Clinic, Center for Health Equity and Community Engagement Research, Jacksonville, FL, USA.

Gafar Alawode (G)

DGI Consult Ltd, Abuja, Nigeria.

Samuel Alabi (S)

Medicaid Cancer Foundation, Abuja, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH